CytomX Therapeutics (6C1) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Nov 05, 2026
- Period Ending
- 2026 (Q3)
- Consensus EPS Forecast
- -0.06
- Last Year’s EPS
- -0.07
After Close (Not Confirmed)
Same Quarter Last Year
CytomX Therapeutics (CH:6C1) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
CH:6C1 Q2 2026 Earnings Report
CH:6C1 Upcoming Earnings
CytomX Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
CH:6C1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.06- | -0.07 | ― | ― | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.06-0.07 | 0 | ― | ― | ||
| May 07, 2026 | 2026 (Q1) | -0.10-0.08 | 0.22 | -137.04% (-0.31) | |||
| Mar 16, 2026 | 2025 (Q4) | -0.08-0.14 | 0.18 | -178.64% (-0.32) | |||
| Nov 06, 2025 | 2025 (Q3) | -0.04-0.07 | 0.06 | -228.57% (-0.13) | ― | ||
| Aug 07, 2025 | 2025 (Q2) | -0.050.00 | -0.07 | 100.00% (+0.07) | ― | ||
| May 12, 2025 | 2025 (Q1) | 0.100.22 | 0.14 | 58.82% (+0.08) | |||
| Mar 06, 2025 | 2024 (Q4) | -0.160.18 | 0.02 | 1000.00% (+0.16) | ― | ||
| Nov 07, 2024 | 2024 (Q3) | -0.140.06 | 0.03 | 75.00% (+0.02) | ― | ||
| Aug 08, 2024 | 2024 (Q2) | -0.08-0.07 | -0.02 | -300.00% (-0.05) | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
FAQ
When does CytomX Therapeutics (CH:6C1) report earnings?
CytomX Therapeutics (CH:6C1) is estimated to report earnings on Nov 05, 2026, After Close (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is CytomX Therapeutics (CH:6C1) earnings time?
CytomX Therapeutics (CH:6C1) earnings time is After Close (Not Confirmed).
What is CH:6C1 EPS forecast?
CH:6C1 EPS forecast for the fiscal quarter 2026 (Q3) is -0.06.
